Skip to main content
. 2013 Oct 15;8(10):e76496. doi: 10.1371/journal.pone.0076496

Table 3. Univariate and multivariate analyses for disease free-interval in the validation set.

Variables Univariate analysis
Multivariate analysis
Relative Risk (95% CI) p Relative Risk (95% CI) p
Age <=50 vs >50 years 0.94 (0.45-1.98) 0.873
Pathological size >20mm vs <=20mm 1.11 (0.42-2.92) 0.827
Grade II/III vs I 2.12 (0.99-4.5) 0.052 1.39 (0.52-3.70) 0.515
PR status Negative vs Positive 0.9 (0.38-2.1) 0.805
Vascular invasion Yes vs No 1.36 (0.55-3.36) 0.512
KI67(IHC) >14 vs < 14% 2.57 (1.16-5.68) 0.020 1.39 (0.48-4.08) 0.544
Genomic Grade GG3 vs GG1 2.59 (1,17-5.73) 0.019 1.16 (0.39-3.48) 0.788
IHC3 score (continuous) 1.01 (1.00-1.01) 0.204
Number of Breakpoints >34 vs <34 3.7 (1.73-7.92) <0.001 3.47 (1.29-9.31) 0.014

vs: versus.